APA (7th ed.) Citation

A, K., J, D., S, S., SE, S., T, H., A, W., . . . RA, W. (2024). Chemokine receptor-targeted PET/CT provides superior diagnostic performance in newly diagnosed marginal zone lymphoma patients: A head-to-head comparison with [18F]FDG. European journal of nuclear medicine and molecular imaging, 51(3), 749. https://doi.org/10.1007/s00259-023-06489-6

Chicago Style (17th ed.) Citation

A, Kosmala, et al. "Chemokine Receptor-targeted PET/CT Provides Superior Diagnostic Performance in Newly Diagnosed Marginal Zone Lymphoma Patients: A Head-to-head Comparison with [18F]FDG." European Journal of Nuclear Medicine and Molecular Imaging 51, no. 3 (2024): 749. https://doi.org/10.1007/s00259-023-06489-6.

MLA (9th ed.) Citation

A, Kosmala, et al. "Chemokine Receptor-targeted PET/CT Provides Superior Diagnostic Performance in Newly Diagnosed Marginal Zone Lymphoma Patients: A Head-to-head Comparison with [18F]FDG." European Journal of Nuclear Medicine and Molecular Imaging, vol. 51, no. 3, 2024, p. 749, https://doi.org/10.1007/s00259-023-06489-6.